Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products

NCT04183491 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

FED

Sponsor class

Conditions

Healthy Subjects
Pharmacokinetics
Pharmacodynamics

Interventions

BIOLOGICAL: Interferon beta-1a
BIOLOGICAL: Interferon beta-1a
BIOLOGICAL: Interferon beta-1a
BIOLOGICAL: Peginterferon beta-1a
BIOLOGICAL: Peginterferon beta-1a
BIOLOGICAL: Peginterferon beta-1a
BIOLOGICAL: Placebo

Sponsor

Food and Drug Administration (FDA)

Collaborators

[object Object]